Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKier Regulatory News (KIE)

Share Price Information for Kier (KIE)

Share Price is delayed by 15 minutes
Get Live Data
216.00    -0.40 (-0.18%)
Bid:
216.00
Ask:
216.40
Spread: 0.40 (0.185%)
Market Cap: £939.64m
KIE Live PriceLast checked at - London Stock Exchange

Intraday Kier Share Chart

Update on trading, FPK programme, strategic review

3 Jun 2019 07:00

RNS Number : 8891A
Kier Group PLC
03 June 2019
Β 

3 June 2019

Β 

Kier Group plc

Β 

Update on trading, Future Proofing Kier programme and strategic review

Kier Group plc ("Kier" or the "Group") today provides an update on its current trading and outlook for the 2019 financial year ("FY2019"), its Future Proofing Kier programme and the timing of the strategic review announced on 15 April 2019.

Β 

Current trading and outlook

Β 

As highlighted in Kier's FY2019 interim results, the Group continues to experience volume pressures within its Highways, Utilities and Housing Maintenance businesses. In addition, whilst continuing to perform well with double digit growth in its orderbook during FY2019, the Buildings business' revenue growth for FY2019 will be lower than previously forecast.

Β 

As a result, Kier now expects that FY2019 revenue will be broadly in line with the Group's reported revenue for the 2018 financial year and currently expects that the Group's underlying operating profit for FY2019 will be c. Β£25 million lower than previous expectations and that the Group is likely to report a net debt position as at 30 June 2019, which would have an adverse impact on its FY2019 average month-end net debt position.

Β 

Against the background of the revised guidance in respect of FY2019, Kier will provide updated guidance for FY2020 with its FY2019 preliminary results announcement on 19 September 2019.

Β 

Future Proofing Kier programme

Β 

The net costs associated with the FPK programme for FY2019 are now expected to be c. Β£15 million higher than previously forecast. In part, this reflects an acceleration of the programme following the appointment of Andrew Davies as Chief Executive. These net costs are in addition to the Β£25 million reduction in operating profit identified above. Kier will provide a further update on the FPK programme when it announces the conclusions of the strategic review.

Β 

Strategic review

Β 

On 15 April 2019, Kier announced that Andrew Davies would lead a strategic review of the Group to consider ways of further simplifying it, the allocation of capital resources across the Group and additional steps to improve cash generation and reduce leverage. Kier confirms that the conclusions of this review will be announced on 30 July 2019.

Β 

Β 

This announcement contains inside information for the purposes of Market Abuse Regulation (Regulation (EU) No. 596/2014). The person responsible for making this announcement on behalf of the Company is Hugh Raven, General Counsel and Company Secretary.

Β 

Β 

- ENDS -

Β 

For further information, please contact:Β 

Β 

Β 

Kier press officeΒ 

+44 (0)1767 355096

Richard Mountain/Nick Hasell, FTI ConsultingΒ 

+44 (0)20 3727 1340

Β 

Β 

This announcement does not constitute an offer of securities by Kier Group plc (the "Company" and, together with its subsidiaries, the "Group"). This announcement may include statements that are, or may be deemed to be, ''forward-looking statements''. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future and may be beyond the Company's or the Group's ability to control or predict. Forward-looking statements are not guarantees of future performance. You are advised to read the section headed ''Principal risks and uncertainties'' in the Company's Annual Report and Accounts for the year ended 30 June 2018 and the section of the Company's rights issue prospectus dated 30 November 2018 entitled "Risk factors" for a further discussion of the factors that could affect the Company's or the Group's future performance and the industry in which it operates. Other than in accordance with its legal or regulatory obligations, the Company does not accept any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
MSCLIFVSRLIVIIA
Date   Source Headline
26th Jun 20266:10 pmRNSTransaction in Own Shares
19th Jun 20266:22 pmRNSTransaction in Own Shares
19th Jun 20266:20 pmRNSDirector/PDMR Shareholding
12th Jun 20266:02 pmRNSTransaction in Own Shares
12th Jun 20266:00 pmRNSDirector/PDMR Shareholding
12th Jun 20267:00 amRNS-RKier wins South West Water c.£140m NSA extension
5th Jun 20266:00 pmRNSTransaction in Own Shares
1st Jun 202612:55 pmRNSTotal Voting Rights
29th May 20266:20 pmRNSTransaction in Own Shares
28th May 20265:47 pmRNSHolding(s) in Company
28th May 20265:45 pmRNSHolding(s) in Company
27th May 20265:45 pmRNSHolding(s) in Company
27th May 202611:45 amRNSDirector/PDMR Shareholding
22nd May 20266:20 pmRNSTransaction in Own Shares
19th May 20264:30 pmRNSDirector/PDMR Shareholding
15th May 20266:25 pmRNSTransaction in Own Shares
15th May 20266:21 pmRNSDirector/PDMR Shareholding
15th May 20261:45 pmRNSHolding(s) in Company
13th May 202610:45 amRNSHolding(s) in Company
11th May 20266:16 pmRNSHolding(s) in Company
11th May 20266:15 pmRNSHolding(s) in Company
8th May 20266:20 pmRNSTransaction in Own Shares
7th May 20269:30 amRNSHolding(s) in Company
1st May 20266:20 pmRNSTransaction in Own Shares
1st May 202611:45 amRNSTotal Voting Rights
30th Apr 20265:44 pmRNSHolding(s) in Company
29th Apr 20266:16 pmRNSHolding(s) in Company
27th Apr 20263:18 pmRNSHolding(s) in Company
27th Apr 20263:17 pmRNSHolding(s) in Company
27th Apr 20267:00 amRNSDirector/PDMR Shareholding
24th Apr 20265:39 pmRNSTransaction in Own Shares
23rd Apr 202611:00 amRNSHolding(s) in Company
20th Apr 20265:20 pmRNSDirector/PDMR Shareholding
20th Apr 20265:20 pmRNSHolding(s) in Company
17th Apr 20266:20 pmRNSTransaction in Own Shares
16th Apr 20266:00 pmRNSHolding(s) in Company
10th Apr 20266:10 pmRNSTransaction in Own Shares
1st Apr 20269:30 amRNSTotal Voting Rights
27th Mar 20265:40 pmRNSTransaction in Own Shares
20th Mar 20265:34 pmRNSTransaction in Own Shares
20th Mar 202610:45 amRNSDirector/PDMR Shareholding
16th Mar 20263:15 pmRNS-RUK’s STEP fusion energy programme appoints Kier
16th Mar 20263:15 pmRNS-RUK’s STEP fusion energy programme appoints Kier
16th Mar 20269:20 amRNSTransaction in Own Shares
16th Mar 20269:20 amRNSTransaction in Own Shares
13th Mar 20269:25 amRNSTransaction in Own Shares
13th Mar 20269:25 amRNSTransaction in Own Shares
12th Mar 20269:33 amRNSTransaction in Own Shares
11th Mar 20263:53 pmRNSDirector/PDMR Shareholding
11th Mar 20263:53 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.